• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX, INC VITEK® 2 AST-YS07 TEST KIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX, INC VITEK® 2 AST-YS07 TEST KIT Back to Search Results
Catalog Number 414967
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
Device not returned to manufacturer.
 
Event Description
A customer in (b)(6) reported the occurrence of false susceptible fluconazole (mic <=1 mg/l) for candida albicans (b)(6) sample in association with the vitek 2 ast-ys07 test kit.Repeat test obtained the same result.As evident from the report from (b)(6), approximately 50% of the laboratories involved in the survey using automated susceptibility testing systems reported the candida albicans strain as susceptible for fluconazole, itraconazole, and voriconazole.There is no indication or report from the laboratory that the discrepant result led to any adverse event related to any patient's state of health.There was no patient directly associated with the survey sample.Culture submittal was requested by biomerieux for internal investigation.Biomerieux investigation will be initiated.
 
Manufacturer Narrative
A customer in denmark reported the occurrence of false susceptible fluconazole (mic <=1 mg/l) for candida albicans neqas sample in association with the vitek® 2 ast-ys07 test kit.An internal investigation was performed.This investigation was initiated due to discrepant results on three (3) drugs ( amphoterin b, fluconazole, voriconazole)on ast-ys07 card for one isolate candida albicans, from an external quality control called neqas (distribution 3789-strain 2938).Neqas information/expected results: -amphotericin b mic = 0.125mg/l s.-fluconazole mic >6 4 mg/l r.-voriconazole mic >8 mg/l r.Please note: in the final report from neqas, fluconazole and voriconazole were not graded since the "levels of concordance with fluconazole (63%) and voriconazole (59%) did not reach the requisite 80% of participants".Biomérieux performed the reference methods to determine the intended results for amphotericin b (broth macrodiution), and for fluconazole and voriconazole (both microdilution), compared to vitek® 2 ast-ys07 cards.Amphotericin b reference mic= 0.5mg/l s, fluconazole ref mic >64 mg/l r and voriconazole ref mic >16 mg/l r were obtained.On vitek® 2, the following were obtained: -from sda media and on 2 ast-ys07 lots: ab mic =8 r (>=16 r) - flu mic =16 i and vrc mic= 1s.-from cos media and on 1 ast-ys07 lot: ab mic =8 r - flu mic <=1s and vrc mic<=0.125 s.Vitek® 2 amphotericin b results (8 - >=16 mg/l r) are in essential agreement error (gap >2 doubling dilutions with the reference mic) which lead to a major error.Vitek® 2 fluconazole results (<=1 mg/l s) and voriconazole results (<=0.125- 1 mg/l s) are in essential agreement errors (gap >2 doubling dilutions with the reference mic) which lead to a very major error for each drug.Biomérieux duplicated the non-reproducible results and the discrepancies with expected neqas values.The investigation concluded that the isolate exhibits atypical growth behavior.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITEK® 2 AST-YS07 TEST KIT
Type of Device
VITEK® 2 AST-YS07 TEST KIT
Manufacturer (Section D)
BIOMERIEUX, INC
595 anglum road
st. louis MO 63042
Manufacturer (Section G)
BIOMERIEUX, INC
595 anglum road
st. louis MO 63042
Manufacturer Contact
ellen weltmer
595 anglum road
hazelwood, MO 63042
3147317301
MDR Report Key6064646
MDR Text Key58824369
Report Number1950204-2016-00160
Device Sequence Number1
Product Code NGZ
Combination Product (y/n)N
Reporter Country CodeDA
PMA/PMN Number
K133817
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 02/17/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/28/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number414967
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/26/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-